IAM (Intellectual Asset Management)

Biocon Biologics Earns Asia IP Elite 2025 Recognition from IAM

Biocon Biologics Limited, a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), has been…